Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues: |
| North America | 1,148.3 | 1,141.4 | 1,543.8 | 1,872.9 | | | 14.1 | 14.1 |
| Europe | 518.2 | 586.7 | 826.3 | 983.0 | | | 11.7 | 9.1 |
| Asia Pacific | 458.3 | 468.0 | 504.0 | 571.2 | | | 6.2 | 6.4 |
| South America | 61.7 | 60.8 | 94.5 | 98.1 | | | 0.0 | |
| Other | 143.7 | 118.5 | 139.7 | 98.9 | | | 3,346.7 | 3,214.4 |
| Total revenues | 2,330.2 | 2,375.4 | 3,108.4 | 3,624.0 | 3,617.8 | 3,472.9 | 3,378.6 | 3,244.0 |
| Revenue growth [+] | -1.9% | -23.6% | -14.2% | 0.2% | 4.2% | 2.8% | 4.2% | 5.0% |
| North America | 0.6% | -26.1% | -17.6% | | | | -0.5% | 21.1% |
| Europe | -11.7% | -29.0% | -15.9% | | | | 28.3% | 2.2% |
| Asia Pacific | -2.1% | -7.1% | -11.8% | | | | -3.4% | -32.5% |
| South America | 1.6% | -35.7% | -3.6% | | | | | |
| Cost of goods sold | 2,243.0 | 2,227.9 | 2,749.3 | 3,075.7 | 2,946.7 | 2,808.1 | 2,755.7 | 2,734.6 |
| Gross profit | 87.2 | 147.5 | 359.1 | 548.3 | 671.1 | 664.8 | 623.0 | 509.4 |
| Gross margin | 3.7% | 6.2% | 11.6% | 15.1% | 18.5% | 19.1% | 18.4% | 15.7% |
| Selling, general and administrative | 227.1 | 263.6 | 302.5 | 314.8 | 341.0 | 356.6 | 329.9 | 301.7 |
| Equity in earnings | 1.7 | 0.4 | 6.5 | 6.7 | 5.5 | 7.9 | 5.7 | 6.0 |
| Other operating expenses | 34.2 | 116.2 | 56.9 | 129.1 | 35.2 | 15.0 | 41.7 | -0.5 |
| EBITDA [+] | -33.4 | -77.6 | 158.2 | 257.8 | 438.5 | 423.7 | 371.4 | 326.8 |
| EBITDA growth | -57.0% | -149.1% | -38.6% | -41.2% | 3.5% | 14.1% | 13.7% | 14.3% |
| EBITDA margin | -1.4% | -3.3% | 5.1% | 7.1% | 12.1% | 12.2% | 11.0% | 10.1% |
| Depreciation | 131.7 | 142.6 | 134.0 | 131.9 | 124.0 | 109.1 | 100.5 | 96.1 |
| EBITA | -165.0 | -220.2 | 24.2 | 125.9 | 314.5 | 314.6 | 270.9 | 230.7 |
| EBITA margin | -7.1% | -9.3% | 0.8% | 3.5% | 8.7% | 9.1% | 8.0% | 7.1% |
| Amortization of intangibles | 7.3 | 11.6 | 18.0 | 14.8 | 14.1 | 13.6 | 13.9 | 16.4 |
| EBIT [+] | -172.4 | -231.8 | 6.2 | 111.1 | 300.4 | 301.0 | 257.0 | 214.2 |
| EBIT growth | -25.6% | -3835.5% | -94.4% | -63.0% | -0.2% | 17.1% | 20.0% | 22.5% |
| EBIT margin | -7.4% | -9.8% | 0.2% | 3.1% | 8.3% | 8.7% | 7.6% | 6.6% |
| Non-recurring items [+] | 35.0 | 36.5 | -156.3 | -6.0 | 28.7 | 46.0 | 75.5 | 43.7 |
| Asset impairment | | | | -45.3 | | | 21.6 | 26.3 |
| Interest expense | 72.5 | 59.2 | 44.1 | 41.0 | 42.1 | 41.4 | 38.3 | 45.6 |
| Interest expense | 72.5 | 59.2 | 44.1 | 41.0 | 42.1 | 41.4 | 38.3 | 45.6 |
| Other income (expense), net [+] | -9.6 | -2.8 | -20.1 | -6.4 | -16.8 | -18.8 | 9.8 | -36.7 |
| Gain (loss) on debt retirement | | | | -0.8 | -1.0 | -5.1 | | |
| Other | -4.8 | -2.6 | -4.3 | -4.8 | -9.4 | -13.7 | 9.8 | -6.2 |
| Pre-tax income | -289.5 | -330.2 | 98.3 | 69.7 | 212.7 | 194.8 | 153.0 | 88.3 |
| Income taxes | 39.4 | -60.8 | 36.1 | -29.4 | 71.5 | 54.3 | 41.2 | 42.8 |
| Tax rate | | 18.4% | 36.7% | | 33.6% | 27.9% | 26.9% | 48.5% |
| Minority interest | -6.0 | -1.8 | -5.3 | -4.5 | 3.3 | 1.5 | -0.1 | 2.7 |
| Net income | -322.8 | -267.6 | 67.5 | 103.6 | 138.0 | 139.0 | 111.9 | 42.8 |
| Net margin | -13.9% | -11.3% | 2.2% | 2.9% | 3.8% | 4.0% | 3.3% | 1.3% |
| |
| Basic EPS [+] | ($18.94) | ($15.82) | $3.94 | $5.79 | $7.76 | $7.96 | $6.50 | $2.56 |
| Growth | 19.7% | -501.7% | -32.0% | -25.4% | -2.5% | 22.5% | 153.7% | 7.3% |
| Diluted EPS [+] | ($18.94) | ($15.82) | $3.92 | $5.66 | $7.35 | $7.42 | $6.08 | $2.39 |
| Growth | 19.7% | -503.2% | -30.7% | -22.9% | -1.0% | 22.1% | 154.2% | 7.3% |
| |
| |
| Shares outstanding (basic) [+] | 17.0 | 16.9 | 17.1 | 17.9 | 17.8 | 17.5 | 17.2 | 16.7 |
| Growth | 0.8% | -1.4% | -4.2% | 0.6% | 1.8% | 1.4% | 3.1% | 13.7% |
| Shares outstanding (diluted) [+] | 17.0 | 16.9 | 17.2 | 18.3 | 18.8 | 18.7 | 18.4 | 17.9 |
| Growth | 0.8% | -1.7% | -5.9% | -2.6% | 0.2% | 1.7% | 2.9% | 13.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|